These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 21872629)

  • 21. A nasally administered trivalent inactivated influenza vaccine is well tolerated, stimulates both mucosal and systemic immunity, and potentially protects against influenza illness.
    Langley JM; Aoki F; Ward BJ; McGeer A; Angel JB; Stiver G; Gorfinkel I; Shu D; White L; Lasko B; Dzongowski P; Papp K; Alexander M; Boivin G; Fries L
    Vaccine; 2011 Feb; 29(10):1921-8. PubMed ID: 21219987
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Oculo-respiratory syndrome following influenza vaccination: review of post-marketing surveillance through four influenza seasons in Canada.
    Can Commun Dis Rep; 2005 Nov; 31(21):217-25. PubMed ID: 16669126
    [No Abstract]   [Full Text] [Related]  

  • 23. Adverse events following pandemic influenza vaccine Pandemrix® reported in the French military forces--2009-2010.
    Mayet A; Ligier C; Gache K; Manet G; Nivoix P; Dia A; Haus-Cheymol R; Verret C; Duron S; Faure N; Piarroux M; De Laval F; Simon F; Decam C; Chaudet H; Meynard JB; Rapp C; Deparis X; Migliani R
    Vaccine; 2011 Mar; 29(14):2576-81. PubMed ID: 21296693
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A comparative trial of influenza immunization by inhalation and hypojet methods.
    Haigh W; Howell RW; Meichen FW
    Practitioner; 1973 Sep; 211(263):365-70. PubMed ID: 4586238
    [No Abstract]   [Full Text] [Related]  

  • 25. Superior relative efficacy of live attenuated influenza vaccine compared with inactivated influenza vaccine in young children with recurrent respiratory tract infections.
    Ashkenazi S; Vertruyen A; Arístegui J; Esposito S; McKeith DD; Klemola T; Biolek J; Kühr J; Bujnowski T; Desgrandchamps D; Cheng SM; Skinner J; Gruber WC; Forrest BD;
    Pediatr Infect Dis J; 2006 Oct; 25(10):870-9. PubMed ID: 17006279
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Serious adverse events following receipt of trivalent inactivated influenza vaccine in Korea, 2003-2010.
    Choe YJ; Cho H; Kim SN; Bae GR; Lee JK
    Vaccine; 2011 Oct; 29(44):7727-32. PubMed ID: 21827815
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Monitoring the safety of annual and pandemic influenza vaccines: lessons from the US experience.
    Iskander J; Broder K
    Expert Rev Vaccines; 2008 Feb; 7(1):75-82. PubMed ID: 18251695
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pandemic influenza A/H1N1 vaccine administered sequentially or simultaneously with seasonal influenza vaccine to HIV-infected children and adolescents.
    Esposito S; Tagliaferri L; Daleno C; Valzano A; Picciolli I; Tel F; Prunotto G; Serra D; Galeone C; Plebani A; Principi N
    Vaccine; 2011 Feb; 29(8):1677-82. PubMed ID: 21199699
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Oculo-respiratory syndrome in association with the influenza vaccine: Canada, October-November 2000.
    Can Commun Dis Rep; 2000 Dec; 26(23):201-2. PubMed ID: 11149349
    [No Abstract]   [Full Text] [Related]  

  • 30. Influenzavirus infection is a primary cause of febrile respiratory illness in HIV-infected adults, despite vaccination.
    Klein MB; Lu Y; DelBalso L; Coté S; Boivin G
    Clin Infect Dis; 2007 Jul; 45(2):234-40. PubMed ID: 17578785
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Predictors of influenza vaccination in HIV-infected patients in the United States, 1990-2002.
    Gallagher KM; Juhasz M; Harris NS; Teshale EH;
    J Infect Dis; 2007 Aug; 196(3):339-46. PubMed ID: 17597447
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Preliminary results: surveillance for Guillain-Barré syndrome after receipt of influenza A (H1N1) 2009 monovalent vaccine - United States, 2009-2010.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2010 Jun; 59(21):657-61. PubMed ID: 20520590
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Acute systemic inflammation induced by influenza A (H1N1) vaccination causes a deterioration in endothelial function in HIV-infected patients.
    Vlachopoulos C; Xaplanteris P; Sambatakou H; Mariolis E; Bratsas A; Christoforatou E; Miliou A; Aznaouridis K; Stefanadis C
    HIV Med; 2011 Nov; 12(10):594-601. PubMed ID: 21645196
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Oculo-respiratory syndrome following influenza vaccination: evidence for occurrence with more than one influenza vaccine.
    De Serres G; Boulianne N; Duval B; Rochette L; Grenier JL; Roussel R; Donaldson D; Tremblay M; Toth E; Ménard S; Landry M; Robert Y
    Vaccine; 2003 Jun; 21(19-20):2346-53. PubMed ID: 12744865
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Adverse reactions of trivalent influenza vaccine in HIV-infected individuals.
    Hajiabdolbaghi M; Jam S; SeyedAlinaghi S; Jafari S; Badie BM; Sabzvari D
    Acta Med Iran; 2010; 48(2):95-100. PubMed ID: 21133001
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Short communication: immunogenicity of an inactivated influenza vaccine and postvaccination influenza surveillance in HIV-infected and noninfected children and adolescents.
    Machado AA; Machado CM; Boas LS; Lopes MC; Gouvêa Ade F; Succi RC; Mendoza TR; Kanashiro TM; Machado DM
    AIDS Res Hum Retroviruses; 2011 Sep; 27(9):999-1003. PubMed ID: 21284525
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immunogenicity and tolerability of an inactivated and adjuvanted pandemic H1N1 influenza vaccine, in HIV-1-infected patients.
    Tremblay CL; Rouleau D; Fortin C; Toma E; Sylla M; Cyr L; Cote S; Baz M; Sampalis J; Trautman L; Sékaly RP; Boivin G
    Vaccine; 2011 Feb; 29(7):1359-63. PubMed ID: 21185423
    [TBL] [Abstract][Full Text] [Related]  

  • 38. No effect of 2008/09 seasonal influenza vaccination on the risk of pandemic H1N1 2009 influenza infection in England.
    Pebody R; Andrews N; Waight P; Malkani R; McCartney C; Ellis J; Miller E
    Vaccine; 2011 Mar; 29(14):2613-8. PubMed ID: 21292008
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Intradermal influenza vaccination in immunocompromized patients is immunogenic and feasible.
    Gelinck LB; van den Bemt BJ; Marijt WA; van der Bijl AE; Visser LG; Cats HA; Rimmelzwaan GF; Kroon FP
    Vaccine; 2009 Apr; 27(18):2469-74. PubMed ID: 19368788
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Reactions following administration of influenza vaccine alone or with pneumococcal vaccine to the elderly.
    Honkanen PO; Keistinen T; Kivelä SL
    Arch Intern Med; 1996 Jan; 156(2):205-8. PubMed ID: 8546555
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.